The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
Improving results despite declining sales: Alföldi Tej Kft. stabilizes after a difficult year
Alföldi Tej Kft. took a breather in 2024: although the…
Read more >BioTechUSA’s new premium vitamin product line is here
This spring, BioTechUSA launched a new, premium vitamin product line,…
Read more >FC DAC 1904 Dunaszerdahely and BioTechUSA enter into partnership
BioTechUSA’s sports sponsorship portfolio has been expanded with another professional…
Read more >Related news
The special retail tax will remain until 2026
The new tax package announced recently brings significant changes for…
Read more >The European Commission demands the abolition of margin squeeze
The European Commission has launched infringement proceedings against Hungary over…
Read more >Mohu’s bottle return role in jeopardy due to a new EU regulation
According to a new European Union regulation, from 2029, only…
Read more >